Cassava Sciences, Inc. (SAVA) Deep Dive Video

Name: Cassava Sciences, Inc. (SAVA) Deep Dive Video | Flash
Uploaded: 2026-01-31T19:28:46.329
Description: A cash-backed biotech “call option” trying to resurrect simufilam via an orphan-epilepsy pivot—blocked (for now) by a decisive FDA clinical hold.

Summary

A cash-backed biotech “call option” trying to resurrect simufilam via an orphan-epilepsy pivot—blocked (for now) by a decisive FDA clinical hold.

View SAVA stock page · Read the SAVA research report

Loading the video player…